Related Experiment Videos
[Cyclic adenosine monophosphate and atherogenic factors]
Voprosy Meditsinskoi Khimii
|November 1, 1977
Summary
High cholesterol reduced adenyl cyclase activity, while high triglycerides increased it. Atherosclerosis impairs adenylate cyclase system activity, potentially due to altered glucocorticoid levels.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Endocrinology
Context:
- Investigates the role of adenylate cyclase in metabolic disorders and cardiovascular disease.
- Examines the impact of hypercholesterolemia and hypertriglyceridemia on enzyme activity.
- Studies adenylate cyclase, phosphodiesterase, and prostaglandin levels in human platelets.
Purpose:
- To determine the activity of the adenylate cyclase system in patients with coronary atherosclerosis and after myocardial infarction.
- To explore the relationship between lipid levels, glucocorticoids, and adenylate cyclase activity.
- To assess potential biochemical markers for ischemic heart disease.
Summary:
- Hypercholesterolemia decreased adenyl cyclase activity in rabbit liver and platelets.
- Hypertriglyceridemia increased adenyl cyclase activity and 3,5-AMP in adipose tissue.
- Platelet adenylate cyclase activity was impaired in patients with coronary atherosclerosis and post-myocardial infarction, possibly linked to glucocorticoid changes.
Impact:
- Suggests adenylate cyclase system dysfunction in atherosclerosis.
- Highlights potential role of glucocorticoids in cardiovascular disease pathogenesis.
- Provides insights into biochemical alterations associated with ischemic heart conditions.